Akèy › Fibroz Pulmonè Idyopatik › Kansas
Etid klinik pou Fibroz Pulmonè Idyopatik nan Kansas
7 etid pou Fibroz Pulmonè Idyopatik ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
Tèks ofisyèl etid la (Anglè)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- The University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Kansas City
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- The University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- University of Kansas, Kansas City
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05571059WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Kansas City, KS, Kansas City
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06967805Interstitial Lung Disease Research Unit Biobank
- The University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05392881Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.